The new target delineation impact on carotid and bulb sparing for T1 glottic cancer: VMAT vs 3DCRT

被引:0
|
作者
Ferella, L. [1 ]
Vittorini, F. [2 ]
Varrassi, E. [3 ]
Franzese, P. [3 ]
Di Staso, M. [3 ]
Marampon, F. [4 ]
Sorce, C. [5 ]
Chalaszczyk, A. [5 ]
Grimaldi, G. [5 ]
Di Cesare, E.
Orlandi, E. [6 ,7 ]
Tombolini, V. [4 ]
Masciocchi, C. [8 ]
Gravina, G. L. [5 ]
机构
[1] Univ Aquila, Fdn IRCC Ist Nazl Tumori Milan, Dept Biotechnol & Appl Clin Sci, Div Radiotherapy,Lab Radiobiol,Radiotherapy Unit, Milan, Italy
[2] San Salvatore Hosp, Serv Med Phys, Laquila, Italy
[3] Univ Aquila, San Salvatore Hosp, Dept Radiat Oncol, Laquila, Italy
[4] Sapienza Univ Rome, Policlin Umberto I Hosp, Dept Radiat Oncol, Rome, Italy
[5] Univ Aquila, Dept Biotechnol & Appl Clin Sci, Div Radiotherapy, Lab Radiobiol, Laquila, Italy
[6] Univ Aquila, Dept Biotechnol & Appl Clin Sci, Div Radiotherapy, Laquila, Italy
[7] Fdn IRCCS Ist Nazl Tumori, Radiotherapy Unit 2, Radiotherapy Unit 1, Milan, Italy
[8] Univ Aquila, Dept Biotechnol & Appl Clin Sci, Laquila, Italy
关键词
D O I
10.1016/S0167-8140(19)31606-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EP-1186
引用
收藏
页码:S657 / S658
页数:2
相关论文
共 37 条
  • [31] Shortening the acquisition time of whole-body MRI: 3D T1 gradient echo Dixon vs fast spin echo for metastatic screening in prostate cancer
    Lecouvet, Frederic E.
    Pasoglou, Vassiliki
    Van Nieuwenhove, Sandy
    Van Haver, Thomas
    de Broqueville, Quentin
    Denolin, Vincent
    Triqueneaux, Perrine
    Tombal, Bertrand
    Michoux, Nicolas
    EUROPEAN RADIOLOGY, 2020, 30 (06) : 3083 - 3093
  • [32] Shortening the acquisition time of whole-body MRI: 3D T1 gradient echo Dixon vs fast spin echo for metastatic screening in prostate cancer
    Frédéric E. Lecouvet
    Vassiliki Pasoglou
    Sandy Van Nieuwenhove
    Thomas Van Haver
    Quentin de Broqueville
    Vincent Denolin
    Perrine Triqueneaux
    Bertrand Tombal
    Nicolas Michoux
    European Radiology, 2020, 30 : 3083 - 3093
  • [33] The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-Guerin
    Gontero, Paolo
    Sylvester, Richard
    Pisano, Francesca
    Joniau, Steven
    Oderda, Marco
    Serretta, Vincenzo
    Larre, Stephane
    Di Stasi, Savino
    Van Rhijn, Bas
    Witjes, Alfred J.
    Grotenhuis, Anne J.
    Colombo, Renzo
    Briganti, Alberto
    Babjuk, Marek
    Soukup, Viktor
    Malmstrom, Per-Uno
    Irani, Jacques
    Malats, Nuria
    Baniel, Jack
    Mano, Roy
    Cai, Tommaso
    Cha, Eugene K.
    Ardelt, Peter
    Vakarakis, John
    Bartoletti, Riccardo
    Dalbagni, Guido
    Shariat, Shahrokh F.
    Xylinas, Evanguelos
    Karnes, Robert J.
    Palou, Joan
    BJU INTERNATIONAL, 2016, 118 (01) : 44 - 52
  • [34] WHO 1973 grade 3 and infiltrative growth pattern proved, aberrant E-cadherin expression tends to be of predictive value for progression in a series of stage T1 high-grade bladder cancer after organ-sparing approach
    Wolfgang Otto
    Johannes Breyer
    Sonja Herdegen
    Fabian Eder
    Simone Bertz
    Matthias May
    Roman Mayr
    Eva M. Lausenmeyer
    Stefan Denzinger
    Bas W. G. van Rhijn
    Maximilian Burger
    Arndt Hartmann
    International Urology and Nephrology, 2017, 49 : 431 - 437
  • [35] WHO 1973 grade 3 and infiltrative growth pattern proved, aberrant E-cadherin expression tends to be of predictive value for progression in a series of stage T1 high-grade bladder cancer after organ-sparing approach
    Otto, Wolfgang
    Breyer, Johannes
    Herdegen, Sonja
    Eder, Fabian
    Bertz, Simone
    May, Matthias
    Mayr, Roman
    Lausenmeyer, Eva M.
    Denzinger, Stefan
    van Rhijn, Bas W. G.
    Burger, Maximilian
    Hartmann, Arndt
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2017, 49 (03) : 431 - 437
  • [36] Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1–2 N1 disease: An individual patient data analysis of three clinical trials; [Auswirkungen der Strahlentherapie nach Mastektomie auf die Ergebnisse von Mammakarzinompatientinnen im Stadium T1–2 N1: Eine individuelle Patientendatenanalyse aus 3 klinischen Studien]
    Abdel-Rahman O.
    Strahlentherapie und Onkologie, 2019, 195 (4) : 297 - 305